Khan, Safeera

Programmed Cell Death Protein 1 (PD-1) and Programmed Cell Death Ligand 1 (PD-L1) Immunotherapy: A Promising Breakthrough in Cancer Therapeutics

Abaza, A., Sid Idris, F., Anis Shaikh, H., Vahora, I., Moparthi, K. P., Al Rushaidi, M. T., Muddam, M. R., Obajeun, O. A., Jaramillo, A. P., & Khan, S. (2023) · Cureus

Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses

Cited by 59

Similarities Between Depression and Neurodegenerative Diseases: Pathophysiology, Challenges in Diagnosis and Treatment Options

Hussain, M., Kumar, P., Khan, S., Gordon, D. K., & Khan, S. (2020) · Cureus

Treatment of Major DepressionDementia and Cognitive Impairment Research

Cited by 49

A Correlation Between the Pathogenic Processes of Fibromyalgia and Irritable Bowel Syndrome in the Middle-Aged Population: A Systematic Review

Valencia, C., Fatima, H., Nwankwo, I., Anam, M., Maharjan, S., Amjad, Z., Abaza, A., Vasavada, A. M., Sadhu, A., & Khan, S. (2022) · Cureus

Gastrointestinal motility and disordersFibromyalgia and Chronic Fatigue Syndrome Research

Cited by 15

Resmetirom: A Systematic Review of the Revolutionizing Approach to Non-alcoholic Steatohepatitis Treatment Focusing on Efficacy, Safety, Cost-Effectiveness, and Impact on Quality of Life

Bittla, P., Paidimarri, S. P., Ayuthu, S., Chauhan, Y. D., Saad, M. Z., Mirza, A. A., & Khan, S. (2024) · Cureus

Liver Disease Diagnosis and TreatmentAlcohol Consumption and Health Effects

Cited by 11

Inclisiran: a systematic review exploring the revolutionary approach of twice-yearly dosing regimen in the treatment of hypercholesterolemia

Singareddy, S., Dhakal, S., Limbaña, T. A., Murugan, V., Nazmin, F., Garcia, J., & Khan, S. (2024) · Cureus

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 0